Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04648397
Other study ID # NL74340.081.20
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 16, 2020
Est. completion date November 27, 2020

Study information

Verified date January 2021
Source Wageningen University and Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to assess the impact of speed of consumption of two starch-based foods varying in fibre content on blood glucose levels in normal healthy subjects. Furthermore, the mediating roles of salivary amylase and particle size on blood glucose levels will be studied. The study has a randomized cross-over design. Subjects consume two test-lunches (chick peas and brown rice) in duplicate on 8 different test days, at either long or short chewing duration. Glucose responses will be monitored via a continuous glucose monitoring device and expectorated boluses will be collected during each test day for assessments of amylase activity and food particle size.


Description:

Research suggests that high glucose level variability and large dips in glucose levels may have a negative impact on cognitive function and self-reported wellbeing. The way food is consumed (e.g. chewing duration) may regulate blood glucose levels. The underlying mechanism that links consumption speed to metabolic responses, satiation and health is largely unknown. This study aims to assess the impact of speed of consumption of two starch-based foods varying in fibre content, on blood glucose levels in normal healthy subjects. Furthermore, the mediating roles of salivary amylase and particle size on blood glucose levels are studied. The study has a randomized cross-over design. Each subject consumes two different test-lunches (chick peas and brown rice) in duplicate at either long or short duration. Their breakfast will be standardized during these 8 test days. For a duration of 12 days, blood glucose levels will be monitored via a continuous glucose device. Furthermore expectorated boluses will be collected for assessment of amylase activity and food particle size.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date November 27, 2020
Est. primary completion date November 27, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Apparently healthy men and women (based on questionnaire, self-reported) - Aged between 18 - 55 yrs - BMI between 18.5 - 30 kg/m2 - In possession of a Smartphone running on iOS or Android Exclusion Criteria: - Diagnosed with Diabetes mellitus type 1 or 2 - Under treatment for neurological or psychiatric complaints, including eating disorders - History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints - Use of medication/supplements that may influence the study results, such as medicines known to interfere with glucose homeostasis. This will be judged by our medical doctor - Following a diet or gained/lost >=5kg weight in the previous month. - Coeliac disease or gluten intolerance - Skin allergy, eczema or known sensitivity for plasters - use of drugs - Current smokers - Using > 14 glasses of alcohol per week - Having a food allergy for the test foods - Participation in another clinical trial at the same time - Suffering from a stomach emptying disorder - Employed by or an intern at the FHCR group of Wageningen Food & Biobased Research.

Study Design


Intervention

Other:
Low glycaemic load, high fibrous product
Test-lunch of 370 grams of chickpeas, seasoned with a herb- and spice mix to increase palatability. Glycaemic load 18.5. Consumed in duplicate.
High glycaemic load, low fibrous product
Test-lunch of 257 grams of brown rice, seasoned with rice-oil and a herb- and spice mix to increase palatability. Glycaemic load 44.9. Consumed in duplicate.

Locations

Country Name City State
Netherlands Stichting Wageningen Research Wageningen Gelderland

Sponsors (1)

Lead Sponsor Collaborator
Wageningen University and Research

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood glucose responses in the 3 hrs following lunch measured by a continuous glucose monitoring device 12 days in total to cover all test days
Secondary Particle size of food bolus measured in food boli of the test-lunches by image analysis on 4 of the 8 test days, at day 1, day 2, day 3 and day 4 or day 5, day 6, day 7 and day 8 depending on group
Secondary Amylase activity measured in saliva at day 1
Secondary In vitro starch digestion rates in food bolus assessed in food boli of the test-lunches by making use of INFOGEST 2.0 protocol on 4 of the 8 test days, at day 1, day 2, day 3 and day 4 or day 5, day 6, day 7 and day 8 depending on group
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04230694 - Continuous Glucose Monitoring of Hospitalized Patients With Diabetes N/A
Active, not recruiting NCT04641689 - Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment N/A
Active, not recruiting NCT05056376 - Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs N/A
Completed NCT04547023 - Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy N/A
Enrolling by invitation NCT04846751 - Exercise Type That Faster Reduces Postprandial Glycemia. N/A
Active, not recruiting NCT04893148 - Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes Phase 4
Active, not recruiting NCT01028846 - Central Mechanisms That Regulate Glucose Metabolism in Humans Phase 4
Completed NCT03252704 - Post-prandial Glycemic Response to Fiber in Healthy Adults N/A
Completed NCT05215210 - The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels N/A
Completed NCT03972878 - Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products N/A
Completed NCT05071950 - The Effect of D-allulose on the Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan Fasting N/A
Suspended NCT03428295 - Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC Phase 1/Phase 2
Suspended NCT03566511 - Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Phase 2
Completed NCT04483453 - Effect of Nutritional Intervention on Metabolic Response in Infants N/A
Completed NCT03344185 - The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day N/A
Completed NCT03544411 - Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM Phase 1
Completed NCT05182190 - Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults N/A
Completed NCT04438018 - Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM
Completed NCT03811132 - Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)
Completed NCT01818674 - Microclinic Social Network Behavioral Health Trial in Jordan N/A